Human AML cells express the NK-1R and, via this receptor, SP and NK-1R antagonists respectively exert a proliferative action or an anti-leukemic effect (apoptotic mechanisms are triggered by promoting oxidative stress via mitochondrial Ca++ overload). The gene discussed is TACR1; the disease is acute myeloid leukemia.